Notably, the cardiovascular outcomes study conducted on adults (SELECT study) revealed a higher incidence of hip and pelvic fractures among female patients receiving semaglutide compared to those on placebo: 1.0% (24/2448) versus 0.2% (5/2424) [80]
Future studies needed To fill existing research gaps, we recommend future studies to examine not only the quantitative change in calorie intake but the qualitative changes in macro- and micronutrient intake including dietary patterns for patients using highly effective anti-obesity medications
Improved energy levels : Provides a noticeable increase in energy, keeping you motivated and active
While the new therapy is exceptional in its volume trajectory and market potential, many launch brands are faced with the challenge of balancing patient access, payer coverage, and transitional assistance impact to margin
In recent years, GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda)have revolutionized the treatment of type 2 diabetes and obesity